WELCOME TO XBIOTECH

XBiotech is working to provide safer and more effective medication to patients through the use of True Human™ antibodies. Our lead product candidate blocks chronic inflammation and represents a possible breakthrough in the treatment of many debilitating diseases—including cancer, diabetes, psoriasis and vascular disease. We are working to change the future of medicine.

NEWS

divider

04.13.12

XBiotech breaking ground on 67,000sf manufacturing facility… -

The first phase of development for the commercial facility that will host production of the world's first True Human™ Antibody…more

divider

03.30.12

XBiotech is pleased to announce FDA approval to launch… -

The study, involving approximately 100 patients, is headed by a world renown…more

divider

12.05.11

XBiotech Presents Oncology Trial Results -

XBiotech recently presented results from its oncology program at the AACR-NCI-EORTC…more

divider

09.24.11

XBiotech Hosts Clinical Investigators -

XBiotech hosted its clinical investigators in vascular disease over the weekend at a conference…more